Rémy Martin And Usher Team Up To Celebrate Two Cultures Of Excellence: Music And Cognac

“Team Up For Excellence – The Film” Imagined in collaboration with FRED & FARID New York, Brings to Life the History of Harmony Between these Cultural Entities Through a Musical Journey

NEW YORK, May 14, 2021 /PRNewswire/ — Today, Rémy Martin announces a collaborative new campaign with multi–Grammy award winning musical artist, Usher to celebrate the harmonious blending of two cultures of timeless excellence: Music and Cognac. “Team Up For Excellence – The Film” highlights the cultural connection between Cognac and American music since 1917 in France, and how the two have been synonymous ever since.

In the Film imagined in collaboration with FRED &FARID New York, Usher narrates a story spanning the decades from the 1920’s to present day, which pays tribute to the multi–cultural connections, celebrated styles and rhythms of the past. From Blues to Hip–Hop, Swing Dancing to Break–Dancing; Usher and Rémy Martin®1738 Accord Royal travel through decades in France and the US, to honor these cultural figures; both rooted in a shared philosophy of aiming for the stars.

“Music doesn’t need Cognac to exist, and Cognac doesn’t need Music to exist,” states Usher, “but what is beautiful is that they were meant to meet and when they did, they created cultural harmony.”

Team Up For Excellence - The Film

Teaming up with Usher and Rémy Martin, are globally recognized creatives including Raphael Saadiq, world–renowned musical composer; Marci Rodgers, Academy–Award winning costume stylist; Aakomon Jones, award winning dance choreographer; and director of the production; Jake Nava.

“I was really inspired by creating the historical music scenes in a way that felt true to the spirit of that moment, but also relevant and eye–catching to a young contemporary audience,” states Jake Nava, “This dual priority informed my direction of all the music, dance and Usher’s performance.”

The heart and soul of cultural movements throughout history paved the way for future artists to innovate, while paying homage to their roots and the musical styles that came before them. The same respect for heritage is honored by Rémy Martin and Cellar Master, Baptiste Loiseau, who has inherited the savoir–faire of the House from previous generations of cellar masters. Through this transmission of knowledge, Rémy Martin®1738 Accord Royal continues to encompass the spirit of celebrating depth of character and the excitement of indulging in moments of collective success.

“Rémy Martin has been at the center of celebration for centuries, and the celebratory nature of Music is synonymous with our history of honoring communities and culture,” said Amaury Vinclet, Global Executive Director of Rémy Martin “Acknowledging this collective success has been at the heart of Rémy Martin since 1724.”

Historically, Rémy Martin and Usher teamed up during his 2010 “OMG” world tour, where the Cognac brand was the official sponsor of after parties across the United States, Canada and Europe. Additionally, Usher co–hosted the launch dinner for Producer Series with Jermaine Dupri in 2018.

“Team Up For Excellence – The Film is a monumental artistic achievement stemming from our collaboration and long–standing relationship with our trusted creative global agency, FRED & FARID,” said Philippe Farnier, Chief Executive Officer for The House of Rémy Martin. “We celebrate this performance between our brand, creative agency and artist Usher. At Rémy Martin, we team up with those sharing our same quest for excellence, rooted in our values of people, terroir and time.”

For almost 300 years, the story of Rémy Martin has been one of family, partners and collective success. Teamwork has always been at the heart of the brand, passing the spirit of collaboration on to younger generations. The desire to team up with others in a quest for excellence has been a part of the Rémy Martin ethos since 1724, with the constant dedication to creating premium Cognac. To continually go further and aspire to achieve more is a reflection of the Centaur, Rémy Martin’s brand figurehead for 150 years. Following the launch in the United States, the short film will be screened and showcased globally.

CREDITS:

Brand: Rémy Martin

Title of ad: Team Up For Excellence – The Film

Agency: FRED & FARID New York

Music: Raphael Saadiq

Costume stylist: Marci Rodgers

Dance choreographer: Aakomon Jones

Director of the production: Jake Nava

For more information visit RemyMartin.com and follow along on social media at:

Instagram @RemyMartinUS | Twitter @RemyMartinUS | Facebook RemyMartinUSA

Media Contact:
Alix de Boisset
International Communication Director
M: +33 6 99 91 44 87
alix.deboisset@remy-cointreau.com

ABOUT RÉMY MARTIN
Since 1724, Rémy Martin has produced premium spirits that consistently appeal to the world’s most discerning connoisseurs. A profound love of the land, a continuity of family ownership and   a passionate commitment to excellence has sustained Rémy Martin for nearly three centuries. As a result of its masterful production and generations of tradition in Cognac, Rémy Martin today produces Fine Champagne Cognacs, including Rémy Martin® XO, Rémy Martin® Tercet, Rémy Martin 1738® Accord Royal and Rémy Martin® V.S.O.P For additional information, visit www.RemyMartin.com.

ABOUT RÉMY MARTIN 1738
Born from the cask and named after a royal approval, Rémy Martin®1738 Accord Royal is a truly distinctive cognac. Its exceptional smoothness and rounded oakiness starts with the toasting of the casks, before the eaux–de–vie even begin to mature. This unique aromatic profile is then revealed through a rigorous selection of eaux–de–vie. Recognized for its outstanding quality year after year in international competitions, Rémy Martin®1738 Accord Royal celebrates true depth of character and the sheer indulgence of sharing good moments.

ABOUT RÉMY COINTREAU
All around the world, there are clients seeking exceptional experiences; clients for whom a wide range of terroirs means a variety of flavors. Their exacting standards are proportional to our expertise – the finely–honed skills that we pass down from generation to generation. The time these clients devote to drinking our products is a tribute to all those who have worked to develop them. It is for these men and women that Rémy Cointreau, a family–owned French Group, protects its terroirs, cultivates exceptional multi–centenary spirits and undertakes to preserve their eternal modernity. The Group’s portfolio includes 12 unique brands, such as the Rémy Martin and Louis XIII Cognacs, and Cointreau liqueur. Rémy Cointreau has a single ambition: becoming the world leader in exceptional spirits. To this end, it relies on the commitment and creativity of its 1,900 employees and on its distribution, subsidiaries established in the Group’s strategic markets. Rémy Cointreau is listed on Euronext Paris.

ABOUT USHER
Challenging himself creatively, testing musical boundaries and being on the creative forefront of new and developing trends are characteristics that have defined Usher throughout his 20 year career. Usher has been ranked by the Recording Industry Assn. of America as one of the best–selling artists in American music history, having sold over 65 million albums worldwide. He has won numerous awards including 8 Grammy Awards and was named the #1 Hot 100 artist of the 2000s decade. Usher has attained nine Hot 100 #1 hits and 18 Hot 100 top–10 singles. His career in TV and Film includes 2 seasons as a coach on NBC’s The Voice as well as starring roles in films such as “Hands of Stone” and “Burden”. 2021 continues to be a busy year for Usher with an upcoming new album release and the launch of his much anticipated Las Vegas residency at Caesar’s Palace. In the past year Usher’s two singles “Don’t Waste My Time” and “Bad Habit” both hit #1 on the Billboard R&B Charts. He also released “I Cry”, a powerful and emotional song about the social and racial injustices of our time. Usher is currently in the studio recording his 9th studio album which will be released late 2021.

ABOUT FRED & FARID New York
FRED & FARID is a purpose driven company producing meaningful ideas, grounding brands into culture. Based in New York, Paris, FRED & FARID New York’s culture is a peculiar mix of the French sense of craft and taste, the Chinese sense of tactic and digital, and the American sense of vision and strategy. The agency focuses on creative consulting, brand strategy, branding, content & social activation, and has produced 1800+ creative campaigns for 250+ brands in 33+ industries, winning 950+ awards and 25+ industry titles – including the AdAge Small Agency 2020 Gold Newcomer of the Year, and Best Integrated Campaign of the Year. Website: www.fredfarid.com

Video – https://www.youtube.com/watch?v=v2hp5LUuRQM
Photo – https://mma.prnewswire.com/media/1510188/72863_SP1_210311_Remy_Martin_Usher_20s_082_h.jpg
Logo – https://mma.prnewswire.com/media/891944/Remy_Martin_Logo.jpg

 

Vinamilk Jumps Six Notches among Global Top 50 Leading Dairy Companies

HO CHI MINH CITY, Vietnam, May 14, 2021 /PRNewswire/ — The Vietnam Dairy Products Joint Stock Company (Vinamilk) recorded an impressive performance in 2020 despite the challenges brought along by the COVID-19 pandemic. With revenue of $2.6 billion in 2020, an increase of 5.9% year-on-year, Vinamilk has jumped 6 notches among the Top 50 leading dairy companies in the world.

According to the 2021 ranking by UK-based Plimsoll Publishing Ltd, Vinamilk currently ranks 36th among the world’s Top 50 dairy producers by total sales. Since 2017, the Vietnamese brand has become the only dairy producer in Vietnam and Southeast Asia to enter the Top 50, along with dairy companies from the U.S., New Zealand, and Europe.

Vinamilk Green farm fresh milk is one of Vinamilk’s newly launched products earlier this year

Part of Vinamilk’s solid earnings is attributed to the company’s 2020 export revenue which hit USD 2.1 billion, through product distribution in 56 countries and territories. Despite the current global economy uncertainty, Vinamilk’s export growth is expected to continue as it has already recorded a 7.9% year-on-year growth rate in the first quarter of 2021.

These achievements continue to cement Vinamilk’s leading position within Vietnam. For the eighth consecutive year, the milk brand has been ‘The Most Chosen Brand’ in dairy and dairy substitute category for both urban and rural areas in Vietnam, according to Kantar Worldpanel’s Asia Brand Footprint 2020.

Vinamilk's overview and key financial highlights (2017 – 2020)

“Besides maintaining stability in production and business, Vinamilk will continue to promote cohesion and value sharing with stakeholders. Sustainable development will be oriented towards advanced models of the world dairy industry, in which action plans and initiatives will be rolled out for all parts of the company’s value chain, from research and development, farm management, to manufacturing and distribution while improving its subsidiaries corporate governance and operational efficiency.” says Ms. Mai Kieu Lien, Vinamilk’s CEO.

Aligned with its direction, Vinamilk is currently investing in “Green farm”, an eco-friendly farming system as one of its sustainable initiatives. The system includes Vinamilk farms in Quang Ngai, Thanh Hoa, and Tay Ninh provinces. Currently, the company owns 13 dairy farms in Vietnam and an organic dairy farm complex in Laos, managing over 150,000 herds of cattle.

Solar power will be deployed on Vinamilk eco-friendly farming system

Other sustainable initiatives of Vinamilk include applying circular economy to optimize the use of natural resources, completing solar power rollout at Vinamilk’s farms across the country, minimizing plastic footprint in the production process, and implementing organic agriculture practices, in line with the company’s sustainable development strategy.

Vinamilk has also set a revenue target of VND 62,160 billion (USD 2.7 billion) for FY2021 after obtaining VND 13,190 billion (USD 570 million) and VND 2,597 billion (USD 113 million) in revenue and profit in 1Q2021. Going forward, Vinamilk will continue to introduce new quality products and maintain product premiumization process selectively.

In 2020, Vinamilk’s corporate governance practices which adopted international standards have resulted in the brand becoming the only Vietnamese company voted as “Southeast Asia Asset Class” according to the ASEAN corporate governance scorecard results.

Photo – https://mma.prnewswire.com/media/1510327/Vinamilk_Green_farm_fresh_milk_Vinamilk_s_newly_launched_product_earlier.jpg
Photo – https://mma.prnewswire.com/media/1510325/Vinamilk_s_overview_key_financial_highlights__2017___2020.jpg
Logo – https://mma.prnewswire.com/media/1510326/1.jpg

PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma

Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act.

RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. Today, three large pharmaceutical companies, along with several other pharmaceutical and biotech companies of all sizes, are using Synoma to link data and conduct analyses across their drug development portfolios.

“Data of all types is widely available from dozens of sources. The missing link, however, is the ability to connect clinical trial data to the insights from real-world data – enabling researchers to understand what is happening outside and after a study in a way that protects privacy,” said Kent Thoelke, Executive Vice President and Chief Scientific Officer, PRA Health Sciences. “Tokenization and linking is the approach researchers can use to glean the greatest insights into drug safety and effectiveness over time.”

PRA can partner with a variety of tokens to multiple sources of information – making it possible to incorporate broader sets of real-world data and revolutionize evidence generation and insights as envisioned by the 21st Century Cures Act.

“Tokenization of siloed patient data sets will be a game-changer for clinical researchers and drug developers,” said Jane Quigley, Senior Vice President, Digital Health, PRA Health Sciences. “Through our acquisition of Symphony Health and partnership with other data sources, we have enabled scientists and research teams to more intelligently evaluate a wider set of data to inform clinical trial protocols, leverage real-world data as eSource, conduct advanced feasibility, speed enrollment and, ultimately, bring novel and differentiated therapies to market faster.”

Contact us to learn more about how Synoma can be applied to clinical studies.

About PRA Health Sciences

PRA Health Sciences is one of the world’s leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes more than 75 offices across North America, Europe, Asia, Latin America, Africa, Australia and the Middle East and more than 19,000 employees worldwide. Since 2000, PRA has participated in approximately 4,000 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 95 drugs. To learn more about PRA, please visit www.prahs.com.

INVESTOR INQUIRIES: InvestorRelations@prahs.com

MEDIA INQUIRIES: Laurie Hurst, Sr. Director, Communications and Public Relations

hurstlaurie@prahs.com | +1 (919) 786-8435

PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma

Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act.

RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. Today, three large pharmaceutical companies, along with several other pharmaceutical and biotech companies of all sizes, are using Synoma to link data and conduct analyses across their drug development portfolios.

“Data of all types is widely available from dozens of sources. The missing link, however, is the ability to connect clinical trial data to the insights from real-world data – enabling researchers to understand what is happening outside and after a study in a way that protects privacy,” said Kent Thoelke, Executive Vice President and Chief Scientific Officer, PRA Health Sciences. “Tokenization and linking is the approach researchers can use to glean the greatest insights into drug safety and effectiveness over time.”

PRA can partner with a variety of tokens to multiple sources of information – making it possible to incorporate broader sets of real-world data and revolutionize evidence generation and insights as envisioned by the 21st Century Cures Act.

“Tokenization of siloed patient data sets will be a game-changer for clinical researchers and drug developers,” said Jane Quigley, Senior Vice President, Digital Health, PRA Health Sciences. “Through our acquisition of Symphony Health and partnership with other data sources, we have enabled scientists and research teams to more intelligently evaluate a wider set of data to inform clinical trial protocols, leverage real-world data as eSource, conduct advanced feasibility, speed enrollment and, ultimately, bring novel and differentiated therapies to market faster.”

Contact us to learn more about how Synoma can be applied to clinical studies.

About PRA Health Sciences

PRA Health Sciences is one of the world’s leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes more than 75 offices across North America, Europe, Asia, Latin America, Africa, Australia and the Middle East and more than 19,000 employees worldwide. Since 2000, PRA has participated in approximately 4,000 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 95 drugs. To learn more about PRA, please visit www.prahs.com.

INVESTOR INQUIRIES: InvestorRelations@prahs.com

MEDIA INQUIRIES: Laurie Hurst, Sr. Director, Communications and Public Relations

hurstlaurie@prahs.com | +1 (919) 786-8435

‫”TelOne زيمبابوي” تختار منصة Tejas TJ1600 DWDM/OTN من أجل توسيع سعة الشبكة

بنغالور، الهند10 مايو 2021/PRNewswire/ — أعلنت شركة Tejas Networks (في بورصة مومباي: 540595) (وفي البورصة الوطنية الهندية: TEJASNET) اليوم أن شركة TelOne -أحد أكبر كيانات الاتصالات في زيمبابوي وموفر خدمة الإنترنت الأقل تكلفة- قد نشرت حل مضاعفة تقسيم الطول الموجي الكثيف (DWDM) المتجانس 100G/100G+ من  Tejas.وتمتلك TelOne أوسع تغطية للشبكة في زيمبابوي مع اتصال عبر البلاد، مرتكزة على بنيتها التحتية الأساسية القوية.  كما تمتلك TelOne اتصالات قوية بالعديد من أنظمة الكابلات تحت سطح البحر، ولديها مساهمة في شركة غرب المحيط الهندي للكابلات (WIOCC)، التي تمتلك حصة كبيرة في نظام الكابل البحري لشرق إفريقيا (EASSy).

Tejas Networks Logo

تم اختيار حل مضاعفة تقسيم الطول الموجي الكثيف/شبكات النقل البصري (100G DWDM/OTN) الحديث من Tejas من قِبَل TelOne بعد عملية تقديم عطاءات تنافسية وتجربة ميدانية ناجحة.  وقد تمكنت Tejas من إثبات سرعة نقل عالية للعديد من لامدا 100G بنجاح، مع تلبية متطلبات الأداء والموثوقية الصارمة بطريقة فعالة من حيث التكلفة.

قال السيد سانجاي ناياك، الرئيس التنفيذي والعضو المنتدب لشركة Tejas Networks، “يسعدنا أن TelOne قد نشرت أحدث تقنيات 100G/100G+ DWDM/OTN من أجل توسيع شبكتها. ويتيح الحل الخاص بنا لعملائنا تنويع قاعدة موردي DWDM الحاليين، واستخدام حلولنا المُثبَتة والفعالة من حيث التكلفة من أجل التوسع والتشغيل البيني”.

قالت السيدة تشيبو متاسا، العضو المنتدب في TelOne، “تُوفِّر TelOne إمكانية الوصول إلى قاعدة واسعة للشبكة في زيمبابوي.  ومع تزايد الطلب على النطاق الترددي والسرعات العالية من عملائنا، كنا نبحث عن حل متعدد الاستخدامات يمكن أن يُوسِّع السعة بشكل كبير في شبكة الألياف الحالية لدينا باستثمارات متزايدة.  لقد انبهرنا بقدرات حل Tejas وقدرته على حمل خدمات 100G بسلاسة دون مشاكل في التشغيل البيني.  كما تحتوي منتجات Tejas على برامج متعددة الاستخدامات وسهلة التكوين والتشغيل.  ونحن نُقدِّر دعم فريق Tejas عالي الاستجابة، والذي كان قادرًا على تصميم وتقديم حل شبكة شامل في أقصر فترة زمنية”.

قال السيد راكيش راجوناندان، نائب الرئيس للمبيعات – Tejas Networks إفريقيا، “في شبكة TelOne، قدمنا حل DWDM/OTN الخاص بنا باستخدام منصة TJ1600 القابلة للتطوير والمتعددة الاستخدامات.  ويفتح الحل الخاص بنا فرصًا جديدة لمقدمي الخدمات من أجل مضاعفة السعة المتاحة على شبكاتهم بأكثر من 10 أضعاف، دون التقيد بنشر شبكتهم الحالية.  كما يُعَد نشر TelOne مثالًا آخر على تقنيتنا المتطورة التي نشرناها عبر العديد من الشبكات في جميع أنحاء إفريقيا”.

لمزيد من المعلومات حول Tejas Networks، قم بزيارة http://www.tejasnetworks.com أو تَواصَل عبر البريد الإلكتروني على ir@tejasnetworks.com

لمزيد من المعلومات حول TelOne، قم بزيارة http://www.telone.co.zw أو تَواصَل عبر البريد الإلكتروني على info@telone.co.zw 

الاتصال الإعلامي:

السيد سانتوش كيشافان
skeshavan@india.tejasnetworks.com

 Tejas Networks

الشعار من: https://mma.prnewswire.com/media/826177/Tejas_Networks_Logo.jpg

China sets eyes on advanced chip production

BEIJING, May 10, 2021 /PRNewswire/ — A news report by China.org.cn on China sets eyes on advanced chip production.

China’s semiconductor industry is speeding up its development of advanced chips as the homegrown 28 nanometer (nm) process is set to enter mass production this year, while the 14 nm process aims to follow suit next year, according to multiple sources.

In the industry, 28 nm is the dividing line between low-to-mid range and mid-to-high end integrated circuit (IC) manufacturing.

https://mma.prnewswire.com/media/1506401/image.jpg

Besides chips for central processing units, graphics processing units and artificial intelligence, other mainstream industrial products such as televisions, air conditioners, automobiles, high-speed trains, satellites, industrial robots, elevators and drones are the most common applications for the 28 nm technology process.

“China urgently needs to move toward mid-to-high end chip production, and being able to produce 28 nm chips means that it can meet most of the demand for chips without relying on other countries,” said Teng Ran, head of the Integrated Circuit Industry Research Center of CCID Consulting, a firm affiliated with a think tank under the Ministry of Industry and Information Technology (MIIT).

According to Teng, as the 14 nm chipmaking process matures next year, Semiconductor Manufacturing International Corporation (SMIC) will join the ranks of Intel, TSMC and Samsung as the first Chinese company to acquire the 14 nm technology and put it into mass production.

Teng said that SMIC’s 14 nm process will be applied in the areas of 5G technology and high-performance computing, and can largely meet the demand.

China’s breakthrough in advanced chipmaking comes at a time when SMIC and other Chinese tech companies are facing major trade restrictions enforced by the United States.

Last year, progress in Chinese chip manufacturing technologies exceeded expectations domestically with breakthroughs in millimeter waves for 5G and the successful tape-out of SMIC’s FinFET N+1 process chip.

China’s IC industry is transforming from high-speed development to high-quality development, Teng said.

According to estimates from the Chinese semiconductor industry, China’s IC sales reached 884.8 billion yuan in 2020, representing an average annual growth rate of 20%, and three times the growth rate of the global IC industry during the same period, said Tian Yulong, chief engineer and spokesperson of the MIIT, at a press conference on March 1.

The IC industry in China achieved impressive and consistent growth during the 13th Five-Year Plan period (2016-2020), with significant improvements to manufacturing techniques, packaging technologies and key equipment materials, said Tian.

“Companies also grew steadily, a number of which emerged as global leaders in design, manufacturing, packaging and testing, and other links on the industrial chain,” Tian added.

While having made progress on multiple fronts, Teng admitted that China is still playing catch-up when it comes to more advanced chip development. He called for more international collaboration as the IC industry is truly a global industry and no country should be isolated from the industry chain.

Photo – https://mma.prnewswire.com/media/1506401/image.jpg